Crossject appoints Director of U.S. Operations

(CercleFinance.com) - Crossject announces the appointment of Tony Tipton as Director of Operations for the United States, in preparation for the commercialization in this country of Zepizure, its emergency treatment for epileptic seizures.


With over 25 years' experience in key sectors of the commercial pharmaceutical industry, he will strengthen pre-commercial activities and mitigate risk in the run-up to Zepizure's US filing.

Tony Tipton joins Crossject from Xequel Bio, where he was Director of Operations and Commercial Affairs, responsible for commercialization strategy and pre-commercial activities for selected assets.

Copyright (c) 2024 CercleFinance.com. All rights reserved.